Total Voting Rights

Summary by AI BETAClose X

Hemogenyx Pharmaceuticals plc announced on 30 September 2026 that its total issued share capital comprises 6,896,786 ordinary shares of 1p each, with no shares held in treasury, resulting in a total of 6,896,786 voting rights. This figure serves as the denominator for shareholders to determine notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Disclaimer*

UK 100

Latest directors dealings